📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Gadeta

1.1 - Company Overview

Gadeta Logo

Gadeta

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cancer immunotherapies developed through a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with enhanced anti-cancer reactivity, including a new cell-based anti-cancer product called T Cells Engineered.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Gadeta

Azanta Logo

Azanta

HQ: Denmark Website
  • Description: Provider of pharmaceutical marketing and distribution services, offering a portfolio that includes Amnisure, Cicatridina, Repadina Plus, Cystistat, Flexi-T, Methadone, Oxandrin, Suplasyn, and development products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azanta company profile →
Ayala Pharmaceuticals Logo

Ayala Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage small molecule therapeutics, including gamma secretase inhibitors that block Notch-pathway activation. Pipeline includes AL101 in Phase 2 for recurrent/metastatic adenoid cystic carcinoma and AL102 in Phase 2/3 for desmoid tumors, with a planned Phase 2 in relapsed/refractory T-cell acute lymphoblastic leukemia. Conducts clinical trials to evaluate safety and efficacy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ayala Pharmaceuticals company profile →
Array BioPharma Logo

Array BioPharma

HQ: United States Website
  • Description: Provider of targeted small molecule drugs, focused on the development and commercialization of treatments for cancer and other high-burden diseases. Partnered drugs include binimetinib (MEK162), encorafenib (LGX818), selumetinib (with AstraZeneca), and danoprevir (with Roche).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Array BioPharma company profile →
Apollomics Logo

Apollomics

HQ: United States Website
  • Description: Provider of oncology biopharmaceuticals discovering and developing mono- and combination therapies to harness the immune system. Pipeline: APL-502 (PD-L1 mAb) and APL-501 (PD-1 mAb) outside mainland China; EO1001/APL-122 (small molecule) for development outside mainland China, Hong Kong and Taiwan; uproleselan/APL-106 and GMI-1687/APL-108 (E-selectin antagonists) in mainland China, Hong Kong, Macau and Taiwan; TYG100/APL-810 in Greater China and South Africa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apollomics company profile →
Boston Biomedical Logo

Boston Biomedical

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on novel therapeutics to treat cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Boston Biomedical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Gadeta

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Gadeta

2.2 - Growth funds investing in similar companies to Gadeta

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Gadeta

4.2 - Public trading comparable groups for Gadeta

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Gadeta

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Gadeta

What does Gadeta do?

Gadeta is a provider of cancer immunotherapies developed through a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with enhanced anti-cancer reactivity, including a new cell-based anti-cancer product called T Cells Engineered.

Who are Gadeta's competitors?

Gadeta's competitors and similar companies include Azanta, Ayala Pharmaceuticals, Array BioPharma, Apollomics, and Boston Biomedical.

Where is Gadeta headquartered?

Gadeta is headquartered in The Netherlands.

How many employees does Gadeta have?

Gadeta has 1,000 employees 🔒.

When was Gadeta founded?

Gadeta was founded in 2010 🔒.

What sector and industry vertical is Gadeta in?

Gadeta is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Gadeta

Who are the top strategic acquirers in Gadeta's sector and industry

Top strategic M&A buyers and acquirers in Gadeta's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Gadeta?

Top strategic M&A buyers groups and sectors for Gadeta include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Gadeta's sector and industry vertical

Which are the top PE firms investing in Gadeta's sector and industry vertical?

Top PE firms investing in Gadeta's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Gadeta's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Gadeta's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Gadeta's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Gadeta include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Gadeta's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Gadeta?

The key public trading comparables and valuation benchmarks for Gadeta include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Gadeta for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Gadeta with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Gadeta's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Gadeta with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Gadeta's' sector and industry vertical?

Access recent funding rounds and capital raises in Gadeta's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Gadeta